Video Center

The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Debu Tripathy, MD on the importance of cdk4/6 for future breast cancer treatments

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center weighs in on how important a role cdk4/6 inhibitors will play in future breast cancer treatments

Published: 08 November 2016

Recent Videos: Breast

video

Julie Gralow, MD, shares her thoughts on new drugs in development for breast cancer.

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, shares her thoughts on investigational drugs in ...

video

Debu Tripathy, MD on the importance of cdk4/6 for future breast cancer treatments

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center weighs in on how ...

video

Debu Tripathy, MD provides update on breast cancer treatment algorithms impacted by PD-L1

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center talks on how PD-L1 ...

video

Lee Schwartzberg, MD, on how liquid biopsies can be used for breast cancer treatment strategies

Lee Schwartzberg, MD, Professor of Medicine, Chief, Division of Hematology Oncology, University of Tennessee Health Science Center, provides insights into ...

video

Julie Gralow, MD, shares perspective on the evolving development immunotherapies in breast cancer

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, shares her perspective on the evolving development ...

video

Mohammad Jahanzeb, MD, FACP on the role of CDK inhibitors and their evolving role in breast cancer

Mohammad Jahanzeb, MD, FACP, Professor of Clinical Medicine, Hematology/Oncology; Medical Director, Sylvester Comprehensive Cancer Center, discusses the role of CDK ...

video

Mohammad Jahanzeb, MD, FACP comments on rising drug costs relative to more effective therapies

Mohammad Jahanzeb, MD, FACP, Professor of Clinical Medicine, Hematology/Oncology; Medical Director, Sylvester Comprehensive Cancer Center, shares his thoughts on the ...

video

Mohammad Jahanzeb, MD, FACP talks about impact of CDK4/6 inhibition added to letrozole

Mohammad Jahanzeb, MD, FACP, Professor of Clinical Medicine, Hematology/Oncology; Medical Director, Sylvester Comprehensive Cancer Center, comments on the results of ...

video

Julie Gralow, MD, shares her thoughts on the topic of liquid biopsy in breast cancer.

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, shares her perspective on the concept of ...

video

Julie Gralow, MD, on the KRISTINE study

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, comment on the KRISTINE study of preoperative ...

video

Julie Gralow, MD, discusses the Monarch 1 study

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, comments on the Monarch 1 study of ...

video

Julie Gralow, MD, discusses the outcomes of the PALOMA-2 study presented at ASCO 2016

Julie Gralow, MD, Professor, Medical Oncology Division, University of Washington School of Medicine, discusses the outcomes of the PALOMA-2 trial ...

video

Jasgit Sachdev, MD, on new drugs for treating patients w/ triple negative breast cancer.

Jasgit Sachdev, MD, Director, Breast & GYN Early Trials Program, HonorHealth Research Institute, shares her thoughts on new drugs in ...

video

Jasgit Sachdev, MD, on liquid biopsy as a promising technology for breast cancer treatment

Jasgit Sachdev, MD, Director, Breast & GYN Early Trials Program, HonorHealth Research Institute, shares her thoughts on liquid biopsy as ...

video

Jasgit Sachdev, MD, discusses the PALOMA-2 randomized study

Jasgit Sachdev, MD, Director, Breast & GYN Early Trials Program, HonorHealth Research Institute, shares her thoughts on the PALOMA-2 randomized ...

video

Lee S. Schwartzberg, MD, FACP on exciting studies for breast cancer investigational agents

Lee S. Schwartzberg, MD, FACP, Professor of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center relays the pipeline’s ...

video

Lee S. Schwartzberg, MD, FACP discussing Paloma 2 study results from ASCO 2016

Lee S. Schwartzberg, MD, FACP, Professor of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center on the results ...

video

Debu Tripathy, MD, provides perspective on the treatment of HER2+ breast cancer patients

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, provides the big picture ...

video

Lee Schwartzberg, MD, interprets the results of the PALOMA-2 study presented at ASCO 2016

Lee Schwartzberg, MD, Professor of Medicine, Chief, Division of Hematology Oncology, University of Tennessee Health Science Center, provides his perspective ...

video

Debu Tripathy, MD on the evidence of palbociclib (Ibrance) efficacy in the PALOMA-2 trial

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center on reaffirmation of efficacy ...

video

Debu Tripathy, MD discusses the PALOMA-2 trial outcomes in ER+/HER2- advanced breast cancer

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center weighs in on the ...

video

Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center describes how hormonal therapies ...

video

Debu Tripathy, MD explains how liquid biopsy figures into breast cancer treatment

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center relays how liquid biopsy ...

video

Debu Tripathy, MD regarding the MONARCH 1 (abemaciclib) study

Debu Tripathy, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center provides an update on ...

Related Videos

video-image

Julie Gralow, MD, shares perspective on the evolving development immunotherapies in breast cancer

video-image

Lee Schwartzberg, MD, interprets the results of the PALOMA-2 study presented at ASCO 2016

video-image

Lee Schwartzberg, MD, on how liquid biopsies can be used for breast cancer treatment strategies

video-image

Julie Gralow, MD, shares her thoughts on the topic of liquid biopsy in breast cancer.

video-image

Julie Gralow, MD, shares her thoughts on new drugs in development for breast cancer.

video-image

Julie Gralow, MD, on the KRISTINE study

video-image

Julie Gralow, MD, discusses the Monarch 1 study

video-image

Julie Gralow, MD, discusses the outcomes of the PALOMA-2 study presented at ASCO 2016

video-image

Jasgit Sachdev, MD, on new drugs for treating patients w/ triple negative breast cancer.

video-image

Jasgit Sachdev, MD, on liquid biopsy as a promising technology for breast cancer treatment

video-image

Jasgit Sachdev, MD, discusses the PALOMA-2 randomized study

video-image

Mohammad Jahanzeb, MD, FACP on the role of CDK inhibitors and their evolving role in breast cancer

video-image

Mohammad Jahanzeb, MD, FACP comments on rising drug costs relative to more effective therapies

video-image

Mohammad Jahanzeb, MD, FACP talks about impact of CDK4/6 inhibition added to letrozole

video-image

Debu Tripathy, MD on the evidence of palbociclib (Ibrance) efficacy in the PALOMA-2 trial

video-image

Debu Tripathy, MD discusses the PALOMA-2 trial outcomes in ER+/HER2- advanced breast cancer

video-image

Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study

video-image

Debu Tripathy, MD provides update on breast cancer treatment algorithms impacted by PD-L1

video-image

Debu Tripathy, MD explains how liquid biopsy figures into breast cancer treatment

video-image

Debu Tripathy, MD regarding the MONARCH 1 (abemaciclib) study

video-image

Debu Tripathy, MD on the importance of cdk4/6 for future breast cancer treatments

video-image

Lee S. Schwartzberg, MD, FACP on exciting studies for breast cancer investigational agents

video-image

Lee S. Schwartzberg, MD, FACP discussing Paloma 2 study results from ASCO 2016

video-image

Debu Tripathy, MD, provides perspective on the treatment of HER2+ breast cancer patients